| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2576119 | The American Journal of Geriatric Pharmacotherapy | 2006 | 14 Pages |
Abstract
A substantial relation has not been established between sex and the second-generation ChEIs currently used in clinical settings for the treatment of AD. If an interaction between sex and ChEI treatment does exist, as suggested in 10 of the studies we analyzed, it is likely to be small and subtle, with much individual variation, as is the case with most neurologic sex differences. Nevertheless, sexual dimorphism in response to ChEI therapy warrants further investigation, especially in regard to its role in the development of novel AD therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
BSci Haywood, MD, PhD, MRCPsych Mukaetova-Ladinska,